Specialty Enzymes Market worth $4317.2 Million by 2018

Tuesday 8 April 2014, Amsterdam

Specialty enzymes are primarily utilized to produce pharmaceuticals, diagnostics solutions, as well as in biocatalysts and research & development. Every activity in the body such as building new tissues, replacing old tissues, converting food to energy, disposing waste materials, and reproduction requires enzymes. Depleting the body’s enzyme capacity is often the cause of pains, sprains, injuries, inflammation, indigestion, immune deficiency, and diseases such as cancer and cardiovascular diseases. Unlike common medicinal products that temporarily relieve a few problems, enzymes address the dominant underlying causes of several health problems since they often bind and act on their target cells with great affinity and specificity and convert multiple target molecules to the desired products.

Specialty enzymes can be natural proteins produced by living organisms. They work as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. They accelerate chemical reactions as well as optimize the yield of the production processes, which include specialty products such as pharmaceuticals, diagnostics solution, and chemicals required in research & biotechnology, etc.

U.S is the key contributor for the growth of specialty enzymes in the North America. Increasing use of specialty enzymes in pharmaceutical, biocatalyst, diagnostics and research & development will drive the growth of the market in the region. U.S pharmaceuticals manufacturer have expanded their production capacity and invested in new technology to meet the demand of industrial in the region. North America is the largest market for the demand of Specialty enzymes with U.S commanding a major share of the market.